Diclofenac potassium

Names

[ Name ]:
Diclofenac potassium

[Synonym ]:
Diclofenic potassium
Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, potassium salt (1:1)
potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic Acid Monopotassium Salt
Diclofenac potassium
2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid, potassium salt
Potassium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate
UNII-L4D5UA6CB4
MFCD00082254
Cataflam
CGP 45840B
CGP-45840B
2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid potassium salt, Diclofenac potassium salt

Biological Activity

[Description]:

Diclofenac potassium is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells[1], and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively[2]. Diclofenac potassium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade[3].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis

Research Areas >> Inflammation/Immunology

Signaling Pathways >> Immunology/Inflammation >> COX

[Target]

Human COX-2:1.3 nM (IC50, in CHO cells)

Human COX-1:4 nM (IC50, in CHO cells)

Ovine COX-2:0.84 nM (IC50)

Ovine COX-1:5.1 nM (IC50)

[In Vitro]

Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM[1]. Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner[3]. Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3[3]. Cell Viability Assay[3] Cell Line: Neural stem cells (NSCs) Concentration: 1, 3, 10, 30, 60 μM Incubation Time: 1 day Result: Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM. Western Blot Analysis[3] Cell Line: Neural stem cells (NSCs) Concentration: 10, 30 or 60 μM Incubation Time: 6 hours Result: The activation of caspase-3 was increased in a concentration-dependent manner.

[In Vivo]

Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal 51Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days[1]. Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats[1]. Animal Model: Male Sprague-Dawley rats (150±200 g)[1] Dosage: 3 mg/kg Administration: Oral administration, b.i.d., for 5 days Result: Resulted in a significant increase in faecal 51Cr excretion. Animal Model: Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model[2] Dosage: 10 mg/kg Administration: Administered via oral route just prior to induction of inflammation Result: Showed in vivo anti-inflammatory activity (% edema inhibition=29.2, 1 h; 22.2, 3 h; 20, 6 h).

[References]

[1]. Riendeau D, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121(1):105-17.

[2]. Labib MB, et al. Design, synthesis of novel isoindoline hybrids as COX-2 inhibitors: Anti-inflammatory, analgesic activities and docking study. Bioorg Chem. 2018 Oct;80:70-80.

[3]. Chiho Kudo, et al. Diclofenac Inhibits Proliferation and Differentiation of Neural Stem Cells. Biochem Pharmacol. 2003 Jul 15;66(2):289-95.

Chemical & Physical Properties

[ Boiling Point ]:
412ºC at 760 mmHg

[ Melting Point ]:
156-158ºC

[ Molecular Formula ]:
C₁₄H₁₀Cl₂KNO₂

[ Molecular Weight ]:
334.239

[ Flash Point ]:
203ºC

[ Exact Mass ]:
332.972565

[ PSA ]:
52.16000

[ LogP ]:
3.10240

[ Vapour Pressure ]:
1.59E-07mmHg at 25°C

Safety Information

[ Symbol ]:

GHS07, GHS09

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H411

[ Precautionary Statements ]:
P301 + P312 + P330

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
22-51/53

[ Safety Phrases ]:
61

[ RIDADR ]:
2811.0

[ HS Code ]:
2922499990

Customs

[ HS Code ]: 2922499990

[ Summary ]:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

Articles

The advantages and limitations of the analgesics available for control of postoperative pain after a dental procedure.

SAAD Dig. 29 , 70-81, (2013)

Chitosan/glucose 1-phosphate as new stable in situ forming depot system for controlled drug delivery.

Eur. J. Pharm. Biopharm. 88(2) , 361-73, (2014)

Chitosan (CS)-based thermosensitive solutions that turn into semi-solid hydrogels upon injection at body temperature have increasingly drawn attention over the last decades as an attractive new type o...

Cystoid macular edema from cancer-associated retinopathy.

Optom. Vis. Sci. 91(4 Suppl 1) , S66-70, (2014)

This article reviews the diagnosis and management of a patient with cancer-associated retinopathy (CAR) secondary to small cell lung cancer who developed a rare presentation of CAR, cystoid macular ed...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.